Our biotechnology company is developing therapies based on cellular mechanisms identified by a world-renowned research group
Our research is based on the innovative concept of Dependence Receptors
Dependence Receptors are trans-membrane proteins that receive signals and transmit them inside cells. They play a key role in the control of tumor development and can be considered as tumor suppressors.
Based on the concept of Dependence Receptors, the therapeutic strategy of NETRIS Pharma is to block the interaction between DRs and their ligands to restore the tumor suppressing functions.